National Bank of Canada
GRCL

National Bank of Canada’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

National Bank of Canada’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$2.79K Sell
2022
Q3 		$5K Sell
2022
Q2 		$10K Sell
2022
Q1 		$168K Sell
2021
Q4 		$1.43M Buy